000 01447 a2200409 4500
005 20250516051359.0
264 0 _c20110815
008 201108s 0 0 eng d
022 _a1474-547X
024 7 _a10.1016/S0140-6736(11)61249-X
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDalerba, Piero
245 0 0 _aBlood-cell banking for workers at the Fukushima Daiichi nuclear power plant.
_h[electronic resource]
260 _bLancet (London, England)
_cAug 2011
300 _a485 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aBlood Banks
650 0 4 _aBlood Preservation
650 0 4 _aBone Neoplasms
_xetiology
650 0 4 _aBone Remodeling
_xdrug effects
650 0 4 _aDenosumab
650 0 4 _aDisasters
650 0 4 _aEarthquakes
650 0 4 _aHumans
650 0 4 _aJapan
650 0 4 _aNuclear Power Plants
650 0 4 _aOccupational Exposure
650 0 4 _aPeripheral Blood Stem Cell Transplantation
650 0 4 _aRANK Ligand
_xadministration & dosage
650 0 4 _aRadiation Injuries
_xdrug therapy
650 0 4 _aRadioactive Hazard Release
650 0 4 _aStrontium Radioisotopes
_xadverse effects
773 0 _tLancet (London, England)
_gvol. 378
_gno. 9790
_gp. 485
856 4 0 _uhttps://doi.org/10.1016/S0140-6736(11)61249-X
_zAvailable from publisher's website
999 _c21066086
_d21066086